β-Blockers After Myocardial Infarction in Patients With Preserved Ejection Fraction

Key Result

β-blockers were associated with improved cardiovascular outcomes in patients with preserved left ventricular ejection fraction after myocardial infarction.

Key Points

• This analysis aims to determine the relationship between β-blocker use and cardiovascular outcomes following myocardial infarction, particularly in patients with preserved left ventricular ejection fraction.
• Conducted a meta-analysis of 4 randomized clinical trials
• Included patients who experienced myocardial infarction
• Focused on those with preserved left ventricular ejection fraction
• Analyzed cardiovascular outcomes associated with β-blocker treatment
• Overall improvement in cardiovascular outcomes was observed with β-blocker use
• Significant benefits noted in patients with preserved left ventricular ejection fraction
• Findings suggest potential therapeutic advantages of β-blockers post-myocardial infarction